Emma Scharfmann

EmmaScharfmann

published a model 1 day ago

updated a Space 2 days ago

published a Space 2 days ago

#30 opened 16 days ago by

#16 opened 16 days ago by

#15 opened 16 days ago by

#14 opened 16 days ago by

#13 opened 16 days ago by

#12 opened 16 days ago by

#29 opened 16 days ago by

#28 opened 16 days ago by

#27 opened 16 days ago by

#26 opened 16 days ago by

#25 opened 16 days ago by

#24 opened 16 days ago by

#23 opened 16 days ago by

#22 opened 16 days ago by

#21 opened 16 days ago by

#20 opened 16 days ago by

#19 opened 16 days ago by

#18 opened 16 days ago by

#17 opened 16 days ago by

#3 opened 16 days ago by

Emma Scharfmann

AI & ML interests

Recent Activity

Organizations

EmmaScharfmann's activity

source: doi:10.3389/frdem.2026.1808512 — Uhlmann 2026 APOE4 genetic testing guidelines perspective

source: doi:10.7554/eLife.71601

source: doi:10.13140/RG.2.2.25832.17927

source: doi:10.1177/0891988705281883

source: doi:10.1111/ahg.12389

source: doi:10.1111/acel.13819

source: doi:10.3233/JAD-210549

source: doi:10.1002/jgc4.70168

source: doi:10.1002/alz.13410

source: doi:10.1016/j.jalz.2019.07.016

source: doi:10.1016/j.tjpad.2025.100394

source: doi:10.1016/S1474-4422(25)00350-3

source: doi:10.3233/JAD-210549 — Qin 2021 race-APOE meta-analysis (77k participants, 133 studies)

source: doi:10.1016/j.tjpad.2025.100394 - Davidson 2025 - obicetrapib p-tau217, BROADWAY substudy

source: doi:10.1016/j.lanhl.2025.100778 - Langbaum 2025 - APOE disclosure, Generation Study 1

source: doi:10.1016/j.jalz.2019.07.016 - Blue 2019 - local ancestry at APOE, Caribbean Hispanics

source: doi:10.1016/S1474-4422(25)00350-3 - Jack 2025 - lifetime/10-yr absolute risk vs amyloid PET

source: doi:10.1002/jgc4.70168 - Rashkin & Prince 2026 - Understanding GINA guide

source: doi:10.1002/alz.13410 - van der Schaar 2023 - AD biomarker disclosure meta-analysis

topic: apoe4/pharmacogenomics - drug-gene interactions for 7 drug classes